Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

This study has been terminated.
(Safety considerations)
Information provided by (Responsible Party):
Dr David Langleben, Jewish General Hospital Identifier:
First received: September 9, 2011
Last updated: April 4, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)